Article info

Images in …
Valuable lessons from treatment of non-small cell lung cancer with erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
Free
  1. dr_shrimali{at}hotmail.com
View Full Text

Citation

Shrimali RK, Correa PD, Rizwanullah M
Valuable lessons from treatment of non-small cell lung cancer with erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor

Publication history

  • First published November 20, 2008.
Online issue publication 
November 20, 2008

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.